GERON CORP Payments to Acquire Interest in Subsidiaries and Affiliates
GERON CORP (GERN) reported Payments to Acquire Interest in Subsidiaries and Affiliates of $0 for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates · last filed 2013-03-15
- GERON CORP payments to acquire interest in subsidiaries and affiliates for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- GERON CORP payments to acquire interest in subsidiaries and affiliates for fiscal 2010 was $23.00K, a 98.86% decline from fiscal 2009.
- GERON CORP payments to acquire interest in subsidiaries and affiliates for fiscal 2009 was $2.01M.
| Period end | Payments to Acquire Interest in Subsidiaries and Affiliates 12 month |
|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-03-07 |
| 2010-12-31 | $23.00K 10-K · filed 2013-03-15 |
| 2009-12-31 | $2.01M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |